Clinical Trial Update: Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating Zevalin (ibritumomab tiuxetan) in combination with non‑myeloablative allogeneic stem cell transplantation for non-Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Non-Hodgkins Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN